Cargando…

Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries

BACKGROUND: Guidelines recommend using risk stratification tools in acute myocardial infarction (AMI) to assist decision‐making. The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS‐2P) has been recently developed to characterize long‐term risk in patients with MI. HYPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Puymirat, Etienne, Bonaca, Marc, Fumery, Maxime, Tea, Victoria, Aissaoui, Nadia, Lemesles, Gilles, Bonello, Laurent, Ducrocq, Grégory, Cayla, Guillaume, Ferrières, Jean, Schiele, François, Simon, Tabassome, Danchin, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712320/
https://www.ncbi.nlm.nih.gov/pubmed/30536449
http://dx.doi.org/10.1002/clc.23131
_version_ 1783446656271777792
author Puymirat, Etienne
Bonaca, Marc
Fumery, Maxime
Tea, Victoria
Aissaoui, Nadia
Lemesles, Gilles
Bonello, Laurent
Ducrocq, Grégory
Cayla, Guillaume
Ferrières, Jean
Schiele, François
Simon, Tabassome
Danchin, Nicolas
author_facet Puymirat, Etienne
Bonaca, Marc
Fumery, Maxime
Tea, Victoria
Aissaoui, Nadia
Lemesles, Gilles
Bonello, Laurent
Ducrocq, Grégory
Cayla, Guillaume
Ferrières, Jean
Schiele, François
Simon, Tabassome
Danchin, Nicolas
author_sort Puymirat, Etienne
collection PubMed
description BACKGROUND: Guidelines recommend using risk stratification tools in acute myocardial infarction (AMI) to assist decision‐making. The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS‐2P) has been recently developed to characterize long‐term risk in patients with MI. HYPOTHESIS: We aimed to assess the TRS‐2P in the French Registry of Acute ST Elevation or non‐ST elevation MI registries. METHODS: We used data from three 1‐month French registries, conducted 5 years apart, from 2005 to 2015, including 13 130 patients with AMI (52% ST‐elevation myocardial infarction [STEMI]). Atherothrombotic risk stratification was performed using the TRS‐2P score. Patients were divided in to three categories: G1 (low‐risk, TRS‐2P = 0/1); G2 (intermediate‐risk, TRS‐2P = 2); and G3 (high‐risk, TRS‐2P ≥ 3). Baseline characteristics and outcomes were analyzed according to TRS‐2P categories. RESULTS: A total of 12 715 patients (in whom TRS‐2P was available) were included. Prevalence of G1, G2, and G3 was 43%, 24%, and 33% respectively. Clinical characteristics and management significantly differed according to TRS‐2P categories. TRS‐2P successfully defined residual risk of death at 1 year (C‐statistic 0.78): 1‐year survival was 98% in G1, 94% in G2, and 78.5% in G3 (P < 0.001). Using Cox multivariate analysis, G3 was independently associated with higher risk of death at 1 year (hazard ratio [HR] 4.61; 95% confidence interval [CI]: 3.61‐5.89), as G2 (HR 2.08; 95% CI: 1.62‐2.65) compared with G1. The score appeared robust and correlated well with mortality in STEMI and NSTEMI populations, as well as in each cohort separately. CONCLUSIONS: The TRS‐2P appears to be a robust risk score, identifying patients at high risk after AMI irrespective of the type of MI and historical period.
format Online
Article
Text
id pubmed-6712320
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-67123202019-08-28 Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries Puymirat, Etienne Bonaca, Marc Fumery, Maxime Tea, Victoria Aissaoui, Nadia Lemesles, Gilles Bonello, Laurent Ducrocq, Grégory Cayla, Guillaume Ferrières, Jean Schiele, François Simon, Tabassome Danchin, Nicolas Clin Cardiol Clinical Investigations BACKGROUND: Guidelines recommend using risk stratification tools in acute myocardial infarction (AMI) to assist decision‐making. The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention (TRS‐2P) has been recently developed to characterize long‐term risk in patients with MI. HYPOTHESIS: We aimed to assess the TRS‐2P in the French Registry of Acute ST Elevation or non‐ST elevation MI registries. METHODS: We used data from three 1‐month French registries, conducted 5 years apart, from 2005 to 2015, including 13 130 patients with AMI (52% ST‐elevation myocardial infarction [STEMI]). Atherothrombotic risk stratification was performed using the TRS‐2P score. Patients were divided in to three categories: G1 (low‐risk, TRS‐2P = 0/1); G2 (intermediate‐risk, TRS‐2P = 2); and G3 (high‐risk, TRS‐2P ≥ 3). Baseline characteristics and outcomes were analyzed according to TRS‐2P categories. RESULTS: A total of 12 715 patients (in whom TRS‐2P was available) were included. Prevalence of G1, G2, and G3 was 43%, 24%, and 33% respectively. Clinical characteristics and management significantly differed according to TRS‐2P categories. TRS‐2P successfully defined residual risk of death at 1 year (C‐statistic 0.78): 1‐year survival was 98% in G1, 94% in G2, and 78.5% in G3 (P < 0.001). Using Cox multivariate analysis, G3 was independently associated with higher risk of death at 1 year (hazard ratio [HR] 4.61; 95% confidence interval [CI]: 3.61‐5.89), as G2 (HR 2.08; 95% CI: 1.62‐2.65) compared with G1. The score appeared robust and correlated well with mortality in STEMI and NSTEMI populations, as well as in each cohort separately. CONCLUSIONS: The TRS‐2P appears to be a robust risk score, identifying patients at high risk after AMI irrespective of the type of MI and historical period. Wiley Periodicals, Inc. 2018-12-27 /pmc/articles/PMC6712320/ /pubmed/30536449 http://dx.doi.org/10.1002/clc.23131 Text en © 2018 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Puymirat, Etienne
Bonaca, Marc
Fumery, Maxime
Tea, Victoria
Aissaoui, Nadia
Lemesles, Gilles
Bonello, Laurent
Ducrocq, Grégory
Cayla, Guillaume
Ferrières, Jean
Schiele, François
Simon, Tabassome
Danchin, Nicolas
Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title_full Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title_fullStr Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title_full_unstemmed Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title_short Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non‐ST Elevation Myocardial Infarction registries
title_sort atherothrombotic risk stratification after acute myocardial infarction: the thrombolysis in myocardial infarction risk score for secondary prevention in the light of the french registry of acute st elevation or non‐st elevation myocardial infarction registries
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712320/
https://www.ncbi.nlm.nih.gov/pubmed/30536449
http://dx.doi.org/10.1002/clc.23131
work_keys_str_mv AT puymiratetienne atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT bonacamarc atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT fumerymaxime atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT teavictoria atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT aissaouinadia atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT lemeslesgilles atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT bonellolaurent atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT ducrocqgregory atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT caylaguillaume atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT ferrieresjean atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT schielefrancois atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT simontabassome atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT danchinnicolas atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries
AT atherothromboticriskstratificationafteracutemyocardialinfarctionthethrombolysisinmyocardialinfarctionriskscoreforsecondarypreventioninthelightofthefrenchregistryofacutestelevationornonstelevationmyocardialinfarctionregistries